glp 1 allodynia Benefit-Risk Assessment of GLP-1 Receptor Agonists: Implications for Dermatologists and Plastic Surgeons | Dermatology and Therapy Frontiers | The immunomodulatory effects

Discontinuation rates for tirzepatide in the 72 week SURMOUNT-1 trial were 4.3%, 7.1% and 6.2% for the three doses and 2.6% for the placebo group

While both options can lead to significant weight loss, one relies on ongoing medication support and the other involves permanent surgical changes to the digestive system

This could be eggs, avocado, or a smoothie with a spoonful of nut butter

Not all products are created equal

Around 85% of people experience plateaus due to metabolic changes, dosage needs, muscle loss, hidden calories, reduced activity, hormonal shifts, or your bodys natural weight "set point." Heres why it happens and how to overcome it: Metabolism slows down as you lose weight

Science 291 , 10011004 (2001)